<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The APOE epsilon4 allele is a well-established risk factor for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>This disease is characterized by a typical progressive <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> pattern, different from that of other primary <z:hpo ids='HP_0000726'>dementias</z:hpo> such as <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> or frontotemporal and vascular <z:hpo ids='HP_0000726'>dementias</z:hpo>, for which there are no conclusive results on the influence of the APOE genotype </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVE: Our aim is to study how the APOE genotype associates with different <z:hpo ids='HP_0000726'>dementia</z:hpo> types, and the association of this genotype with mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and age related <z:hpo ids='HP_0001268'>cognitive decline</z:hpo>, which might be stages in a continuum between normality and <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: From a group of 1,022 people we selected 733 patients with different <z:hpo ids='HP_0000726'>dementia</z:hpo> diagnosis and 205 controls </plain></SENT>
<SENT sid="4" pm="."><plain>APOE genotype for each participant in the study was determined </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: As it was already known, the epsilon4 allele is associated to senile <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (OR= 5.6; 95% CI= 3.6-8.9; p&lt; 0.001) and presenile <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (OR= 5.4; 95% CI= 2.1-13.8; p&lt; 0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>It is also associated to mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (OR= 3.7; 95% CI= 2.3-6.0; p&lt; 0.001) and to age related <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> (OR= 3.0; 95% CI= 1.2-7.3; p&lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Female Alzheimer patients with at least one epsilon4 allele present significantly an earlier age at <z:hpo ids='HP_0003674'>onset</z:hpo> (epsilon4+= 73.4 +/- 5.4; epsilon4- = 76.9 +/- 5.5; p&lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The APOE genotype is associated to <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and to its <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> pattern </plain></SENT>
<SENT sid="9" pm="."><plain>This association has a growing value according to the degree of clinical impairment </plain></SENT>
<SENT sid="10" pm="."><plain>The APOE genotype could be used in differential diagnostic of <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> </plain></SENT>
</text></document>